nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproheptadine—HTR2C—choroid plexus—malignant glioma	0.0946	0.177	CbGeAlD
Cyproheptadine—HTR2A—choroid plexus—malignant glioma	0.0474	0.0886	CbGeAlD
Cyproheptadine—HTR2C—telencephalic ventricle—malignant glioma	0.0277	0.0518	CbGeAlD
Cyproheptadine—HTR2A—cerebellar cortex—malignant glioma	0.0239	0.0446	CbGeAlD
Cyproheptadine—HTR1A—telencephalic ventricle—malignant glioma	0.0233	0.0436	CbGeAlD
Cyproheptadine—DRD2—telencephalic ventricle—malignant glioma	0.0211	0.0394	CbGeAlD
Cyproheptadine—HTR2A—pons—malignant glioma	0.0169	0.0316	CbGeAlD
Cyproheptadine—HTR2A—vertebral column—malignant glioma	0.0168	0.0313	CbGeAlD
Cyproheptadine—HTR2A—telencephalic ventricle—malignant glioma	0.0139	0.026	CbGeAlD
Cyproheptadine—HTR2A—pineal body—malignant glioma	0.0121	0.0225	CbGeAlD
Cyproheptadine—HTR6—telencephalon—malignant glioma	0.0115	0.0215	CbGeAlD
Cyproheptadine—Clozapine—CALY—malignant glioma	0.00845	0.27	CrCbGaD
Cyproheptadine—Cholestasis—Temozolomide—malignant glioma	0.00772	0.0479	CcSEcCtD
Cyproheptadine—HTR2C—brainstem—malignant glioma	0.0075	0.014	CbGeAlD
Cyproheptadine—HTR2A—endothelium—malignant glioma	0.00746	0.0139	CbGeAlD
Cyproheptadine—CHRM2—telencephalon—malignant glioma	0.0069	0.0129	CbGeAlD
Cyproheptadine—HTR2A—blood vessel—malignant glioma	0.00688	0.0129	CbGeAlD
Cyproheptadine—HTR2C—telencephalon—malignant glioma	0.00665	0.0124	CbGeAlD
Cyproheptadine—HTR6—central nervous system—malignant glioma	0.00654	0.0122	CbGeAlD
Cyproheptadine—HTR1A—brainstem—malignant glioma	0.00631	0.0118	CbGeAlD
Cyproheptadine—CHRM1—telencephalon—malignant glioma	0.00628	0.0117	CbGeAlD
Cyproheptadine—SLC6A2—brainstem—malignant glioma	0.00626	0.0117	CbGeAlD
Cyproheptadine—HTR2B—telencephalon—malignant glioma	0.00625	0.0117	CbGeAlD
Cyproheptadine—DRD2—brainstem—malignant glioma	0.0057	0.0107	CbGeAlD
Cyproheptadine—CHRM3—telencephalon—malignant glioma	0.00562	0.0105	CbGeAlD
Cyproheptadine—HTR1A—telencephalon—malignant glioma	0.0056	0.0105	CbGeAlD
Cyproheptadine—SLC6A2—telencephalon—malignant glioma	0.00555	0.0104	CbGeAlD
Cyproheptadine—DRD2—retina—malignant glioma	0.0055	0.0103	CbGeAlD
Cyproheptadine—HTR2C—medulla oblongata—malignant glioma	0.00523	0.00977	CbGeAlD
Cyproheptadine—HTR6—brain—malignant glioma	0.0052	0.00971	CbGeAlD
Cyproheptadine—Amitriptyline—NTRK2—malignant glioma	0.00506	0.162	CrCbGaD
Cyproheptadine—DRD2—telencephalon—malignant glioma	0.00506	0.00945	CbGeAlD
Cyproheptadine—HTR2C—midbrain—malignant glioma	0.00478	0.00893	CbGeAlD
Cyproheptadine—Hepatic failure—Temozolomide—malignant glioma	0.00474	0.0294	CcSEcCtD
Cyproheptadine—Nasal congestion—Temozolomide—malignant glioma	0.00467	0.029	CcSEcCtD
Cyproheptadine—HTR2C—spinal cord—malignant glioma	0.00466	0.00871	CbGeAlD
Cyproheptadine—Diplopia—Carmustine—malignant glioma	0.00441	0.0273	CcSEcCtD
Cyproheptadine—SLC6A2—medulla oblongata—malignant glioma	0.00436	0.00815	CbGeAlD
Cyproheptadine—Diplopia—Temozolomide—malignant glioma	0.00426	0.0264	CcSEcCtD
Cyproheptadine—HTR2A—embryo—malignant glioma	0.0041	0.00767	CbGeAlD
Cyproheptadine—HTR1A—midbrain—malignant glioma	0.00402	0.00751	CbGeAlD
Cyproheptadine—HRH1—telencephalon—malignant glioma	0.004	0.00746	CbGeAlD
Cyproheptadine—Diphenylpyraline—SLC6A3—malignant glioma	0.00395	0.126	CrCbGaD
Cyproheptadine—HTR1A—spinal cord—malignant glioma	0.00392	0.00733	CbGeAlD
Cyproheptadine—CHRM2—central nervous system—malignant glioma	0.00392	0.00733	CbGeAlD
Cyproheptadine—HTR2C—central nervous system—malignant glioma	0.00378	0.00706	CbGeAlD
Cyproheptadine—HTR2A—brainstem—malignant glioma	0.00376	0.00703	CbGeAlD
Cyproheptadine—DRD2—midbrain—malignant glioma	0.00363	0.00679	CbGeAlD
Cyproheptadine—HTR2A—retina—malignant glioma	0.00363	0.00678	CbGeAlD
Cyproheptadine—Sweating increased—Temozolomide—malignant glioma	0.00359	0.0222	CcSEcCtD
Cyproheptadine—CHRM1—central nervous system—malignant glioma	0.00357	0.00667	CbGeAlD
Cyproheptadine—HTR2B—central nervous system—malignant glioma	0.00355	0.00664	CbGeAlD
Cyproheptadine—Pollakiuria—Temozolomide—malignant glioma	0.0034	0.0211	CcSEcCtD
Cyproheptadine—Photosensitivity reaction—Temozolomide—malignant glioma	0.00336	0.0208	CcSEcCtD
Cyproheptadine—Weight increased—Temozolomide—malignant glioma	0.00335	0.0208	CcSEcCtD
Cyproheptadine—HTR2A—telencephalon—malignant glioma	0.00334	0.00623	CbGeAlD
Cyproheptadine—Neuropathy peripheral—Carmustine—malignant glioma	0.00333	0.0206	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Temozolomide—malignant glioma	0.00322	0.0199	CcSEcCtD
Cyproheptadine—CHRM3—central nervous system—malignant glioma	0.0032	0.00597	CbGeAlD
Cyproheptadine—HTR1A—central nervous system—malignant glioma	0.00318	0.00595	CbGeAlD
Cyproheptadine—SLC6A2—central nervous system—malignant glioma	0.00316	0.0059	CbGeAlD
Cyproheptadine—Amitriptyline—NTRK1—malignant glioma	0.00313	0.1	CrCbGaD
Cyproheptadine—CHRM2—brain—malignant glioma	0.00312	0.00582	CbGeAlD
Cyproheptadine—HTR1A—cerebellum—malignant glioma	0.00311	0.00581	CbGeAlD
Cyproheptadine—Hallucination—Carmustine—malignant glioma	0.00303	0.0188	CcSEcCtD
Cyproheptadine—HTR2C—brain—malignant glioma	0.003	0.00561	CbGeAlD
Cyproheptadine—Hepatitis—Temozolomide—malignant glioma	0.00295	0.0183	CcSEcCtD
Cyproheptadine—Hallucination—Temozolomide—malignant glioma	0.00293	0.0182	CcSEcCtD
Cyproheptadine—DRD2—central nervous system—malignant glioma	0.00288	0.00537	CbGeAlD
Cyproheptadine—CHRM1—brain—malignant glioma	0.00284	0.0053	CbGeAlD
Cyproheptadine—HTR2B—brain—malignant glioma	0.00282	0.00527	CbGeAlD
Cyproheptadine—DRD2—cerebellum—malignant glioma	0.00281	0.00525	CbGeAlD
Cyproheptadine—Tinnitus—Temozolomide—malignant glioma	0.00275	0.017	CcSEcCtD
Cyproheptadine—Chills—Temozolomide—malignant glioma	0.00264	0.0164	CcSEcCtD
Cyproheptadine—HTR2A—medulla oblongata—malignant glioma	0.00262	0.0049	CbGeAlD
Cyproheptadine—CHRM3—brain—malignant glioma	0.00254	0.00474	CbGeAlD
Cyproheptadine—HTR1A—brain—malignant glioma	0.00253	0.00472	CbGeAlD
Cyproheptadine—SLC6A2—brain—malignant glioma	0.00251	0.00468	CbGeAlD
Cyproheptadine—Vision blurred—Carmustine—malignant glioma	0.0025	0.0155	CcSEcCtD
Cyproheptadine—Tremor—Carmustine—malignant glioma	0.00249	0.0154	CcSEcCtD
Cyproheptadine—Agitation—Carmustine—malignant glioma	0.00244	0.0151	CcSEcCtD
Cyproheptadine—Vision blurred—Temozolomide—malignant glioma	0.00242	0.015	CcSEcCtD
Cyproheptadine—Tremor—Temozolomide—malignant glioma	0.0024	0.0149	CcSEcCtD
Cyproheptadine—Carbamazepine—CYP2B6—malignant glioma	0.0024	0.0768	CrCbGaD
Cyproheptadine—HTR2A—midbrain—malignant glioma	0.0024	0.00448	CbGeAlD
Cyproheptadine—Leukopenia—Carmustine—malignant glioma	0.00238	0.0147	CcSEcCtD
Cyproheptadine—Agitation—Temozolomide—malignant glioma	0.00236	0.0146	CcSEcCtD
Cyproheptadine—HTR2A—spinal cord—malignant glioma	0.00234	0.00437	CbGeAlD
Cyproheptadine—Vertigo—Temozolomide—malignant glioma	0.0023	0.0143	CcSEcCtD
Cyproheptadine—Convulsion—Carmustine—malignant glioma	0.0023	0.0143	CcSEcCtD
Cyproheptadine—Leukopenia—Temozolomide—malignant glioma	0.0023	0.0142	CcSEcCtD
Cyproheptadine—DRD2—brain—malignant glioma	0.00228	0.00427	CbGeAlD
Cyproheptadine—HRH1—central nervous system—malignant glioma	0.00227	0.00424	CbGeAlD
Cyproheptadine—Palpitations—Temozolomide—malignant glioma	0.00227	0.014	CcSEcCtD
Cyproheptadine—Convulsion—Temozolomide—malignant glioma	0.00222	0.0138	CcSEcCtD
Cyproheptadine—Mianserin—CYP2B6—malignant glioma	0.00221	0.0707	CrCbGaD
Cyproheptadine—Confusional state—Carmustine—malignant glioma	0.00218	0.0135	CcSEcCtD
Cyproheptadine—Oedema—Carmustine—malignant glioma	0.00217	0.0134	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Carmustine—malignant glioma	0.00212	0.0131	CcSEcCtD
Cyproheptadine—Tachycardia—Carmustine—malignant glioma	0.00211	0.0131	CcSEcCtD
Cyproheptadine—Confusional state—Temozolomide—malignant glioma	0.00211	0.0131	CcSEcCtD
Cyproheptadine—Oedema—Temozolomide—malignant glioma	0.00209	0.013	CcSEcCtD
Cyproheptadine—Anorexia—Carmustine—malignant glioma	0.00206	0.0128	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Temozolomide—malignant glioma	0.00205	0.0127	CcSEcCtD
Cyproheptadine—Hypotension—Carmustine—malignant glioma	0.00202	0.0125	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Temozolomide—malignant glioma	0.00202	0.0125	CcSEcCtD
Cyproheptadine—Anorexia—Temozolomide—malignant glioma	0.002	0.0124	CcSEcCtD
Cyproheptadine—Insomnia—Carmustine—malignant glioma	0.00196	0.0121	CcSEcCtD
Cyproheptadine—Paraesthesia—Carmustine—malignant glioma	0.00194	0.0121	CcSEcCtD
Cyproheptadine—Somnolence—Carmustine—malignant glioma	0.00193	0.0119	CcSEcCtD
Cyproheptadine—HTR2A—central nervous system—malignant glioma	0.0019	0.00354	CbGeAlD
Cyproheptadine—Insomnia—Temozolomide—malignant glioma	0.00189	0.0117	CcSEcCtD
Cyproheptadine—Mianserin—SLC6A3—malignant glioma	0.00188	0.0603	CrCbGaD
Cyproheptadine—Decreased appetite—Carmustine—malignant glioma	0.00188	0.0117	CcSEcCtD
Cyproheptadine—Paraesthesia—Temozolomide—malignant glioma	0.00188	0.0116	CcSEcCtD
Cyproheptadine—Somnolence—Temozolomide—malignant glioma	0.00186	0.0115	CcSEcCtD
Cyproheptadine—HTR2A—cerebellum—malignant glioma	0.00185	0.00346	CbGeAlD
Cyproheptadine—Constipation—Carmustine—malignant glioma	0.00185	0.0115	CcSEcCtD
Cyproheptadine—Dyspepsia—Temozolomide—malignant glioma	0.00184	0.0114	CcSEcCtD
Cyproheptadine—Decreased appetite—Temozolomide—malignant glioma	0.00182	0.0113	CcSEcCtD
Cyproheptadine—Fatigue—Temozolomide—malignant glioma	0.0018	0.0112	CcSEcCtD
Cyproheptadine—HRH1—brain—malignant glioma	0.0018	0.00337	CbGeAlD
Cyproheptadine—Constipation—Temozolomide—malignant glioma	0.00179	0.0111	CcSEcCtD
Cyproheptadine—Feeling abnormal—Carmustine—malignant glioma	0.00178	0.0111	CcSEcCtD
Cyproheptadine—Feeling abnormal—Temozolomide—malignant glioma	0.00172	0.0107	CcSEcCtD
Cyproheptadine—Urticaria—Temozolomide—malignant glioma	0.00166	0.0103	CcSEcCtD
Cyproheptadine—Asthenia—Carmustine—malignant glioma	0.00155	0.00963	CcSEcCtD
Cyproheptadine—HTR2A—brain—malignant glioma	0.00151	0.00281	CbGeAlD
Cyproheptadine—Asthenia—Temozolomide—malignant glioma	0.0015	0.00931	CcSEcCtD
Cyproheptadine—Loxapine—SLC6A3—malignant glioma	0.0015	0.0479	CrCbGaD
Cyproheptadine—Diarrhoea—Carmustine—malignant glioma	0.00148	0.00918	CcSEcCtD
Cyproheptadine—Dizziness—Carmustine—malignant glioma	0.00143	0.00888	CcSEcCtD
Cyproheptadine—Diarrhoea—Temozolomide—malignant glioma	0.00143	0.00888	CcSEcCtD
Cyproheptadine—Dizziness—Temozolomide—malignant glioma	0.00138	0.00858	CcSEcCtD
Cyproheptadine—Vomiting—Carmustine—malignant glioma	0.00138	0.00853	CcSEcCtD
Cyproheptadine—Amitriptyline—CYP2B6—malignant glioma	0.00137	0.0439	CrCbGaD
Cyproheptadine—Rash—Carmustine—malignant glioma	0.00137	0.00846	CcSEcCtD
Cyproheptadine—Dermatitis—Carmustine—malignant glioma	0.00136	0.00846	CcSEcCtD
Cyproheptadine—Headache—Carmustine—malignant glioma	0.00136	0.00841	CcSEcCtD
Cyproheptadine—Vomiting—Temozolomide—malignant glioma	0.00133	0.00825	CcSEcCtD
Cyproheptadine—Rash—Temozolomide—malignant glioma	0.00132	0.00818	CcSEcCtD
Cyproheptadine—Dermatitis—Temozolomide—malignant glioma	0.00132	0.00817	CcSEcCtD
Cyproheptadine—Headache—Temozolomide—malignant glioma	0.00131	0.00813	CcSEcCtD
Cyproheptadine—Nortriptyline—PTGS1—malignant glioma	0.0013	0.0416	CrCbGaD
Cyproheptadine—Nausea—Carmustine—malignant glioma	0.00129	0.00797	CcSEcCtD
Cyproheptadine—Nausea—Temozolomide—malignant glioma	0.00124	0.00771	CcSEcCtD
Cyproheptadine—CHRM1—Signaling Pathways—CD80—malignant glioma	3.69e-05	0.000136	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—KRAS—malignant glioma	3.69e-05	0.000136	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—APC—malignant glioma	3.69e-05	0.000136	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—PIK3CG—malignant glioma	3.69e-05	0.000136	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CD80—malignant glioma	3.68e-05	0.000135	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—APC—malignant glioma	3.67e-05	0.000135	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—PIK3CG—malignant glioma	3.67e-05	0.000135	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—KRAS—malignant glioma	3.67e-05	0.000135	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—EGF—malignant glioma	3.66e-05	0.000135	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—EGF—malignant glioma	3.66e-05	0.000134	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CD80—malignant glioma	3.65e-05	0.000134	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—EGF—malignant glioma	3.64e-05	0.000134	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—PTPN11—malignant glioma	3.64e-05	0.000134	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—APC—malignant glioma	3.64e-05	0.000134	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—PIK3CG—malignant glioma	3.64e-05	0.000134	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—PTPN11—malignant glioma	3.63e-05	0.000134	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—EGF—malignant glioma	3.63e-05	0.000134	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—PTPN11—malignant glioma	3.62e-05	0.000133	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—FGF2—malignant glioma	3.61e-05	0.000133	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—PTPN11—malignant glioma	3.61e-05	0.000133	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—EGF—malignant glioma	3.6e-05	0.000132	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—FGF2—malignant glioma	3.59e-05	0.000132	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—PTPN11—malignant glioma	3.58e-05	0.000131	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—BRAF—malignant glioma	3.54e-05	0.00013	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—MMP9—malignant glioma	3.52e-05	0.00013	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—PTEN—malignant glioma	3.5e-05	0.000129	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—BRAF—malignant glioma	3.48e-05	0.000128	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—BRAF—malignant glioma	3.48e-05	0.000128	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—VEGFA—malignant glioma	3.47e-05	0.000127	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—BRAF—malignant glioma	3.47e-05	0.000127	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—BRAF—malignant glioma	3.45e-05	0.000127	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—AKT2—malignant glioma	3.45e-05	0.000127	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—STAT3—malignant glioma	3.43e-05	0.000126	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—EGFR—malignant glioma	3.43e-05	0.000126	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—BRAF—malignant glioma	3.42e-05	0.000126	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—AKT1—malignant glioma	3.42e-05	0.000126	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—PIK3CA—malignant glioma	3.39e-05	0.000125	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—AKT2—malignant glioma	3.39e-05	0.000125	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—AKT2—malignant glioma	3.38e-05	0.000124	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—MDM2—malignant glioma	3.38e-05	0.000124	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—EGFR—malignant glioma	3.38e-05	0.000124	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—PIK3CA—malignant glioma	3.37e-05	0.000124	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—AKT2—malignant glioma	3.37e-05	0.000124	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—EGFR—malignant glioma	3.37e-05	0.000124	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—PIK3CB—malignant glioma	3.37e-05	0.000124	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—RAF1—malignant glioma	3.37e-05	0.000124	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—AKT2—malignant glioma	3.36e-05	0.000124	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—MDM2—malignant glioma	3.36e-05	0.000124	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—EGFR—malignant glioma	3.36e-05	0.000123	CbGpPWpGaD
Cyproheptadine—UGT1A3—Metabolism—AKT1—malignant glioma	3.36e-05	0.000123	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—RAF1—malignant glioma	3.35e-05	0.000123	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—EGFR—malignant glioma	3.35e-05	0.000123	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—PTGS2—malignant glioma	3.34e-05	0.000123	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—ERBB2—malignant glioma	3.33e-05	0.000122	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—AKT2—malignant glioma	3.33e-05	0.000122	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—EGFR—malignant glioma	3.32e-05	0.000122	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—ERBB2—malignant glioma	3.31e-05	0.000122	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—PIK3CD—malignant glioma	3.31e-05	0.000122	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—PIK3CB—malignant glioma	3.29e-05	0.000121	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR downstream signaling—PIK3CA—malignant glioma	3.28e-05	0.000121	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—PIK3CB—malignant glioma	3.27e-05	0.00012	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—PIK3CD—malignant glioma	3.26e-05	0.00012	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—PIK3CD—malignant glioma	3.25e-05	0.00012	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—KRAS—malignant glioma	3.24e-05	0.000119	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—PIK3CD—malignant glioma	3.24e-05	0.000119	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—PIK3CD—malignant glioma	3.23e-05	0.000119	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR downstream signaling—PIK3CA—malignant glioma	3.23e-05	0.000119	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR downstream signaling—PIK3CA—malignant glioma	3.22e-05	0.000118	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR downstream signaling—PIK3CA—malignant glioma	3.21e-05	0.000118	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR downstream signaling—PIK3CA—malignant glioma	3.2e-05	0.000118	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—PIK3CD—malignant glioma	3.2e-05	0.000118	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—KRAS—malignant glioma	3.19e-05	0.000117	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—MYC—malignant glioma	3.19e-05	0.000117	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—KRAS—malignant glioma	3.18e-05	0.000117	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—KRAS—malignant glioma	3.17e-05	0.000117	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—FGF2—malignant glioma	3.17e-05	0.000117	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR downstream signaling—PIK3CA—malignant glioma	3.17e-05	0.000116	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—VEGFA—malignant glioma	3.16e-05	0.000116	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—KRAS—malignant glioma	3.16e-05	0.000116	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—CXCL8—malignant glioma	3.16e-05	0.000116	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—CXCL8—malignant glioma	3.14e-05	0.000116	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—STAT3—malignant glioma	3.13e-05	0.000115	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—KRAS—malignant glioma	3.13e-05	0.000115	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—FGF2—malignant glioma	3.12e-05	0.000115	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—EGFR—malignant glioma	3.12e-05	0.000115	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—FGF2—malignant glioma	3.11e-05	0.000114	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—FGF2—malignant glioma	3.1e-05	0.000114	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—FGF2—malignant glioma	3.09e-05	0.000114	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—FGF2—malignant glioma	3.06e-05	0.000113	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCR downstream signaling—AKT1—malignant glioma	3.05e-05	0.000112	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCR downstream signaling—AKT1—malignant glioma	3.04e-05	0.000112	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—CASP3—malignant glioma	3.02e-05	0.000111	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—IL2—malignant glioma	3.02e-05	0.000111	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—CASP3—malignant glioma	3.01e-05	0.000111	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—IL2—malignant glioma	3e-05	0.00011	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—PIK3CA—malignant glioma	2.98e-05	0.000109	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—MDM2—malignant glioma	2.97e-05	0.000109	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—RAF1—malignant glioma	2.96e-05	0.000109	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—KRAS—malignant glioma	2.95e-05	0.000108	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—PIK3CA—malignant glioma	2.93e-05	0.000108	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—ERBB2—malignant glioma	2.92e-05	0.000108	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—PIK3CA—malignant glioma	2.92e-05	0.000107	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—MDM2—malignant glioma	2.92e-05	0.000107	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—PIK3CA—malignant glioma	2.91e-05	0.000107	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—MDM2—malignant glioma	2.91e-05	0.000107	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—MYC—malignant glioma	2.91e-05	0.000107	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—PTEN—malignant glioma	2.91e-05	0.000107	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—RAF1—malignant glioma	2.91e-05	0.000107	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—PIK3CA—malignant glioma	2.91e-05	0.000107	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—MDM2—malignant glioma	2.9e-05	0.000107	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—RAF1—malignant glioma	2.9e-05	0.000107	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—MDM2—malignant glioma	2.89e-05	0.000106	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—RAF1—malignant glioma	2.89e-05	0.000106	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—PIK3CB—malignant glioma	2.89e-05	0.000106	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—RAF1—malignant glioma	2.88e-05	0.000106	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—ERBB2—malignant glioma	2.88e-05	0.000106	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—PIK3CA—malignant glioma	2.88e-05	0.000106	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—ERBB2—malignant glioma	2.87e-05	0.000106	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—MDM2—malignant glioma	2.87e-05	0.000105	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—ERBB2—malignant glioma	2.86e-05	0.000105	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—MMP9—malignant glioma	2.86e-05	0.000105	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—RAF1—malignant glioma	2.86e-05	0.000105	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—ERBB2—malignant glioma	2.85e-05	0.000105	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—EGFR—malignant glioma	2.85e-05	0.000105	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—MMP9—malignant glioma	2.84e-05	0.000104	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—PTEN—malignant glioma	2.84e-05	0.000104	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—PIK3CB—malignant glioma	2.84e-05	0.000104	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—PIK3CB—malignant glioma	2.83e-05	0.000104	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—PTEN—malignant glioma	2.83e-05	0.000104	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—ERBB2—malignant glioma	2.83e-05	0.000104	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—PIK3CB—malignant glioma	2.82e-05	0.000104	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—PIK3CB—malignant glioma	2.82e-05	0.000103	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—PIK3CB—malignant glioma	2.79e-05	0.000102	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CXCL8—malignant glioma	2.77e-05	0.000102	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—AKT1—malignant glioma	2.77e-05	0.000102	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—AKT1—malignant glioma	2.76e-05	0.000101	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CXCL8—malignant glioma	2.73e-05	0.0001	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CXCL8—malignant glioma	2.72e-05	0.0001	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CXCL8—malignant glioma	2.71e-05	9.98e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—PIK3CA—malignant glioma	2.71e-05	9.95e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CXCL8—malignant glioma	2.71e-05	9.95e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—KRAS—malignant glioma	2.69e-05	9.89e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CXCL8—malignant glioma	2.68e-05	9.85e-05	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR downstream signaling—AKT1—malignant glioma	2.68e-05	9.85e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CASP3—malignant glioma	2.65e-05	9.76e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—IL2—malignant glioma	2.65e-05	9.74e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR downstream signaling—AKT1—malignant glioma	2.64e-05	9.69e-05	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR downstream signaling—AKT1—malignant glioma	2.63e-05	9.67e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR downstream signaling—AKT1—malignant glioma	2.62e-05	9.64e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—TP53—malignant glioma	2.62e-05	9.63e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR downstream signaling—AKT1—malignant glioma	2.61e-05	9.61e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CASP3—malignant glioma	2.61e-05	9.6e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—IL2—malignant glioma	2.61e-05	9.59e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CASP3—malignant glioma	2.61e-05	9.58e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—IL2—malignant glioma	2.6e-05	9.57e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CASP3—malignant glioma	2.6e-05	9.55e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—IL2—malignant glioma	2.59e-05	9.54e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CASP3—malignant glioma	2.59e-05	9.52e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR downstream signaling—AKT1—malignant glioma	2.59e-05	9.51e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—IL2—malignant glioma	2.59e-05	9.5e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—VEGFA—malignant glioma	2.57e-05	9.43e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CASP3—malignant glioma	2.56e-05	9.43e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—IL2—malignant glioma	2.56e-05	9.41e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—VEGFA—malignant glioma	2.55e-05	9.38e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—STAT3—malignant glioma	2.54e-05	9.34e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—STAT3—malignant glioma	2.53e-05	9.29e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—MMP9—malignant glioma	2.51e-05	9.22e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—PTEN—malignant glioma	2.49e-05	9.17e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—PIK3CA—malignant glioma	2.47e-05	9.08e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—MMP9—malignant glioma	2.47e-05	9.07e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—MMP9—malignant glioma	2.46e-05	9.05e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—MMP9—malignant glioma	2.46e-05	9.02e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—PTEN—malignant glioma	2.45e-05	9.02e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—PTEN—malignant glioma	2.45e-05	9e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—MMP9—malignant glioma	2.45e-05	9e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—PTEN—malignant glioma	2.44e-05	8.97e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—AKT1—malignant glioma	2.43e-05	8.94e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—PTEN—malignant glioma	2.43e-05	8.94e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—MMP9—malignant glioma	2.42e-05	8.91e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—PTEN—malignant glioma	2.41e-05	8.86e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—AKT1—malignant glioma	2.39e-05	8.8e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—TP53—malignant glioma	2.39e-05	8.79e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—AKT1—malignant glioma	2.39e-05	8.78e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—AKT1—malignant glioma	2.38e-05	8.75e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—AKT1—malignant glioma	2.37e-05	8.72e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—MYC—malignant glioma	2.36e-05	8.68e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—AKT1—malignant glioma	2.35e-05	8.64e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—MYC—malignant glioma	2.35e-05	8.63e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—EGFR—malignant glioma	2.31e-05	8.49e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—EGFR—malignant glioma	2.3e-05	8.44e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—VEGFA—malignant glioma	2.25e-05	8.28e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—STAT3—malignant glioma	2.23e-05	8.2e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—VEGFA—malignant glioma	2.22e-05	8.15e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—VEGFA—malignant glioma	2.21e-05	8.13e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—AKT1—malignant glioma	2.21e-05	8.13e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—VEGFA—malignant glioma	2.2e-05	8.1e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—VEGFA—malignant glioma	2.2e-05	8.08e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—STAT3—malignant glioma	2.19e-05	8.07e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—STAT3—malignant glioma	2.19e-05	8.05e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—STAT3—malignant glioma	2.18e-05	8.02e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—KRAS—malignant glioma	2.18e-05	8.02e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—VEGFA—malignant glioma	2.18e-05	8e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—STAT3—malignant glioma	2.18e-05	8e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—KRAS—malignant glioma	2.17e-05	7.98e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—STAT3—malignant glioma	2.15e-05	7.92e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—MYC—malignant glioma	2.07e-05	7.62e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—PIK3CA—malignant glioma	2.05e-05	7.55e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—MYC—malignant glioma	2.04e-05	7.5e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—MYC—malignant glioma	2.03e-05	7.48e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—MYC—malignant glioma	2.03e-05	7.46e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—EGFR—malignant glioma	2.03e-05	7.45e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—MYC—malignant glioma	2.02e-05	7.43e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—AKT1—malignant glioma	2.02e-05	7.42e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—PIK3CA—malignant glioma	2e-05	7.37e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—MYC—malignant glioma	2e-05	7.36e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—EGFR—malignant glioma	1.99e-05	7.33e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—PIK3CA—malignant glioma	1.99e-05	7.33e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—EGFR—malignant glioma	1.99e-05	7.32e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—EGFR—malignant glioma	1.98e-05	7.29e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—EGFR—malignant glioma	1.98e-05	7.27e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—EGFR—malignant glioma	1.96e-05	7.2e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—TP53—malignant glioma	1.94e-05	7.13e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—TP53—malignant glioma	1.93e-05	7.09e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—KRAS—malignant glioma	1.92e-05	7.04e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—KRAS—malignant glioma	1.88e-05	6.93e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—KRAS—malignant glioma	1.88e-05	6.91e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—KRAS—malignant glioma	1.87e-05	6.89e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—KRAS—malignant glioma	1.87e-05	6.87e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—KRAS—malignant glioma	1.85e-05	6.8e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—PIK3CA—malignant glioma	1.76e-05	6.47e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—PIK3CA—malignant glioma	1.73e-05	6.36e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—PIK3CA—malignant glioma	1.73e-05	6.35e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—PIK3CA—malignant glioma	1.72e-05	6.33e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—PIK3CA—malignant glioma	1.72e-05	6.31e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—TP53—malignant glioma	1.7e-05	6.26e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—PIK3CA—malignant glioma	1.7e-05	6.25e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—AKT1—malignant glioma	1.68e-05	6.16e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—TP53—malignant glioma	1.67e-05	6.16e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—TP53—malignant glioma	1.67e-05	6.14e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—TP53—malignant glioma	1.67e-05	6.12e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—TP53—malignant glioma	1.66e-05	6.1e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—TP53—malignant glioma	1.64e-05	6.04e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—AKT1—malignant glioma	1.64e-05	6.02e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—AKT1—malignant glioma	1.63e-05	5.99e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—AKT1—malignant glioma	1.44e-05	5.28e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—AKT1—malignant glioma	1.41e-05	5.2e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—AKT1—malignant glioma	1.41e-05	5.19e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—AKT1—malignant glioma	1.41e-05	5.17e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—AKT1—malignant glioma	1.4e-05	5.15e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—AKT1—malignant glioma	1.39e-05	5.1e-05	CbGpPWpGaD
